Skip to main content

Peer Review reports

From: Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database

Original Submission
7 Sep 2010 Submitted Original manuscript
4 Oct 2010 Reviewed Reviewer Report - Sonal Singh
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
15 Feb 2011 Author responded Author comments - Maryse Lapeyre-Mestre
Resubmission - Version 4
15 Feb 2011 Submitted Manuscript version 4
17 Feb 2011 Reviewed Reviewer Report - Sonal Singh
2 Apr 2011 Author responded Author comments - Maryse Lapeyre-Mestre
Resubmission - Version 5
2 Apr 2011 Submitted Manuscript version 5
3 Apr 2011 Author responded Author comments - Maryse Lapeyre-Mestre
Resubmission - Version 6
3 Apr 2011 Submitted Manuscript version 6
3 Apr 2011 Author responded Author comments - Maryse Lapeyre-Mestre
Resubmission - Version 7
3 Apr 2011 Submitted Manuscript version 7
3 Apr 2011 Author responded Author comments - Maryse Lapeyre-Mestre
Resubmission - Version 8
3 Apr 2011 Submitted Manuscript version 8
Resubmission - Version 9
Submitted Manuscript version 9
17 May 2011 Author responded Author comments - Maryse Lapeyre-Mestre
Resubmission - Version 10
17 May 2011 Submitted Manuscript version 10
Publishing
24 May 2011 Editorially accepted
24 May 2011 Article published 10.1186/1472-6904-11-5

You can find further information about peer review here.

Back to article page